reports
- Emmanuel Matot
- Marc Lavaud
- Michael B. Schäfer
- Marc Lavaud
- Michael B. Schäfer
- Andreas Riemann
CTS Eventim AG & Co. KGaA : Q3 a mixed bag, outlook confirmed, we lowe...
>Double-digit top-line growth but sharp profit decline - Yesterday, CTS Eventim released mixed Q3 2024 results. In Q3 2024, revenue rose 13% y-o-y to € 825m, 8% above the consensus despite a very tough base. The Ticketing business was up 19%, supported by major artists including Ed Sheeran, Iron Maiden, Gilberto Gil and Vasco Rossi. Live Entertainment sales grew 11%. Adjusted EBITDA decreased 30% y-o-y to € 121m, 16% below consensus. Last year’s payment from autoticke...
- Martin Marandon-Carlhian
- Stephane Houri
- Andreas Riemann
CTS Eventim AG & Co. KGaA : Q3 earnings: top line above, profits below...
>Double-digit top line growth in Q3, but sharp decline in EBITDA - In Q3 2024, revenue increased 13% y-o-y to € 825m (consensus: € 765m, ODDO BHFe: € 763m) 8% above the consensus despite a very tough base. The Ticketing business was up 19% and Live Entertainment sales grew 11%. Adjusted EBITDA decreased 30% y-o-y to € 121m (consensus: € 144m, ODDO BHFe: € 143m), 16% below consensus. Last year’s payment from autoticket (€ 38m) inflated adjusted EBITDA in Q3 2023. Bu...
- Martin Marandon-Carlhian
- Stephane Houri
EQS-News: Aufsichtsrat beruft Carsten Schmitt zum neuen CFO
EQS-News: Commerzbank Aktiengesellschaft / Schlagwort(e): Personalie Aufsichtsrat beruft Carsten Schmitt zum neuen CFO 21.11.2024 / 10:02 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Der Aufsichtsrat der Commerzbank hat in seiner heutigen Sitzung Carsten Schmitt zum Chief Financial Officer (CFO) in den Vorstand berufen. Er folgt in dieser Funktion auf Bettina Orlopp, die seit März 2020 Finanzvorständin der Commerzbank war und diese Position mit Übernahme des Vorstandsvorsitzes als Chief Executive Officer (CEO) am 1. Oktober zusätzl...
EQS-News: Supervisory Board appoints Carsten Schmitt as new CFO
EQS-News: Commerzbank Aktiengesellschaft / Key word(s): Personnel Supervisory Board appoints Carsten Schmitt as new CFO 21.11.2024 / 10:02 CET/CEST The issuer is solely responsible for the content of this announcement. In today’s meeting, the Supervisory Board of Commerzbank, has appointed Carsten Schmitt as Chief Financial Officer (CFO) to the Board of Managing Directors. He is going to succeed Bettina Orlopp in this function, who has been Commerzbank’s CFO since March 2020 and has additionally held this position with her role as CEO since 1 October. The handover is plan...
Supervisory Board appoints Carsten Schmitt as new CFO
Commerzbank Aktiengesellschaft (CZB) Supervisory Board appoints Carsten Schmitt as new CFO 21-Nov-2024 / 10:04 CET/CEST The issuer is solely responsible for the content of this announcement. In today’s meeting, the Supervisory Board of Commerzbank, has appointed Carsten Schmitt as Chief Financial Officer (CFO) to the Board of Managing Directors. He is going to succeed Bettina Orlopp in this function, who has been Commerzbank’s CFO since March 2020 and has additionally held this position with her role as CEO since 1 October. The handover is planned to be completed by spring 2025 at...
EQS-News: CTS EVENTIM: Umsatz durchbricht 2-Milliarden-Euro-Schallmaue...
EQS-News: CTS Eventim AG & Co. KGaA / Schlagwort(e): Quartals-/Zwischenmitteilung/9-Monatszahlen CTS EVENTIM: Umsatz durchbricht 2-Milliarden-Euro-Schallmauer erstmals nach neun Monaten (News mit Zusatzmaterial) 21.11.2024 / 08:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Pressemitteilung CTS EVENTIM: Umsatz durchbricht 2-Milliarden-Euro-Schallmauer erstmals nach neun Monaten Starkes Wachstum in den ersten neun Monaten: Konzernumsatz +15,8 Prozent auf 2,027 Milliarden Euro, Adjusted EBITDA +12,1 Prozent auf 322,7 Millionen Euro...
EQS-News: CTS EVENTIM: revenue breaks through the EUR 2 billion barrie...
EQS-News: CTS Eventim AG & Co. KGaA / Key word(s): Quarterly / Interim Statement/9 Month figures CTS EVENTIM: revenue breaks through the EUR 2 billion barrier for the first time in a nine-month period (news with additional features) 21.11.2024 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. Press Release CTS EVENTIM: revenue breaks through the EUR 2 billion barrier for the first time in a nine-month period Strong growth in the first three quarters of 2024: consolidated revenue rises by 15.8% to EUR 2.027 billion and adjusted EBITD...
Rexel: Disclosure of trading in own shares from November 11 to Novembe...
Rexel: Disclosure of trading in own shares from November 11 to November 15, 2024 RELEASE DISCLOSURE OF TRADING IN OWN SHARES FROM NOVEMBER 11 TO NOVEMBER 15, 2024 In accordance with the authorization granted by the Shareholders’ Meeting in order to trade in own shares and pursuant to applicable law on share repurchases, Rexel declares the following purchases of its own shares from November 11 to November 15, 2024: Name of the issuer Identity code of the issuer (Legal Entity Identifier) Day of transaction Identity code of the financial instrument Total dai...
Bylvay® (odevixibat) data shows sustained improvement in severe itch a...
Bylvay® (odevixibat) data shows sustained improvement in severe itch and serum bile acid levels in patients with PFIC and ALGS Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024 PARIS, FRANCE, 18 November, 2024 Ipsen (Euronext: IPN; ADR: IPSEY) today announced data at the American Association for the Study of Liver Diseases (AASLD) assessing the long-term efficacy and safety of patients treated with Bylvay® from two Phase III open-label extension studies: late-breaking abstract (#5045) on PEDFIC 2 in Progressive Famili...
Bylvay® (odévixibat) montre une amélioration soutenue en termes de sév...
Bylvay® (odévixibat) montre une amélioration soutenue en termes de sévérité des démangeaisons et de taux d’acides biliaires sériques chez les patients atteints de CIFP et du SAG Ipsen met en avant 3 nouvelles présentations ainsi que 8 abstracts dans le cadre de son portefeuille de maladies cholestatiques rares du foie au congrès 2024 de l’AASLD. PARIS, FRANCE, le 18 novembre 2024 Ipsen (Euronext : IPN ; ADR : IPSEY) annonce aujourd’hui la présentation de données lors du congrès de l’American Association for the Study of Liver Diseases (AASLD) évaluant l’efficacité et le prof...
- Carole Braudeau
- Carole Braudeau
Rexel: Disclosure of trading in own shares from November 4 to November...
Rexel: Disclosure of trading in own shares from November 4 to November 8, 2024 RELEASE DISCLOSURE OF TRADING IN OWN SHARES FROM NOVEMBER 4 TO NOVEMBER 8, 2024 In accordance with the authorization granted by the Shareholders’ Meeting in order to trade in own shares and pursuant to applicable law on share repurchases, Rexel declares the following purchases of its own shares from November 4 to November 8, 2024: Name of the issuer Identity code of the issuer (Legal Entity Identifier) Day of transaction Identity code of the financial instrument Total dai...
- ING Helpdesk
Rexel: Statement relating to the total number of shares and voting rig...
Rexel: Statement relating to the total number of shares and voting rights Rexel: Statement relating to the total number of shares and voting rights pursuant to Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Rules of the French Autorité des marchés financiers DateNumber of sharesNumber of voting rights2024-10-31 298,233,069 Theoretical number of voting rights(1): 298,233,069Exercisable number of voting rights(2): 296,658,211(1) Number of voting rights including treasury shares deprived from voting rights.(2) Number of voting rights excluding...
Ipsen - October 2024 - Monthly information relative to the total numbe...
Ipsen - October 2024 - Monthly information relative to the total number of voting rights and shares composing the share capital Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation of the Autorité des Marchés Financiers) Market: Euronext Paris ISIN Code: FR 0010259150LEI: 549300M6SGDPB4Z94P11 Date Total number of shares composing the share capital Total number of voting righ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.